CLINICAL TRIALS PROFILE FOR ARTESUNATE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for ARTESUNATE
Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|---|
New Combination | NCT00203801 ↗ | Combination Antimalarials in Uncomplicated Malaria | Completed | Global Fund | N/A | 2002-01-01 | The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine. |
New Combination | NCT00203801 ↗ | Combination Antimalarials in Uncomplicated Malaria | Completed | Medical Research Council, South Africa | N/A | 2002-01-01 | The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine. |
New Combination | NCT00203801 ↗ | Combination Antimalarials in Uncomplicated Malaria | Completed | World Health Organization | N/A | 2002-01-01 | The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine. |
>Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for ARTESUNATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00111163 ↗ | Intermittent Preventive Treatment With Antimalarials in Kenyan Infants | Completed | Bill and Melinda Gates Foundation | N/A | 2004-03-01 | The purpose of the study is to see whether antimalarial drugs administered at the time of routine infant vaccinations prevents malaria and anemia in the first year of life. |
NCT00111163 ↗ | Intermittent Preventive Treatment With Antimalarials in Kenyan Infants | Completed | Kenya Medical Research Institute | N/A | 2004-03-01 | The purpose of the study is to see whether antimalarial drugs administered at the time of routine infant vaccinations prevents malaria and anemia in the first year of life. |
NCT00111163 ↗ | Intermittent Preventive Treatment With Antimalarials in Kenyan Infants | Completed | Centers for Disease Control and Prevention | N/A | 2004-03-01 | The purpose of the study is to see whether antimalarial drugs administered at the time of routine infant vaccinations prevents malaria and anemia in the first year of life. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ARTESUNATE
Condition Name
Clinical Trial Locations for ARTESUNATE
Trials by Country
Clinical Trial Progress for ARTESUNATE
Clinical Trial Phase
Clinical Trial Sponsors for ARTESUNATE
Sponsor Name